Current status and new treatment approaches in TP53 mutated AML
Year: 2019
Type: review
Authors: Anthony M. Hunter, David A. Sallman
Institutions: University of South Florida, Moffitt Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W2944248311
